{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T11:59:51Z","timestamp":1789387191007,"version":"build-2803163510"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"No funding"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12879-015-1329-6","type":"journal-article","created":{"date-parts":[[2015,12,29]],"date-time":"2015-12-29T08:47:51Z","timestamp":1451378871000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":66,"title":["Incidence and characteristics of invasive fungal diseases in allogeneic hematopoietic stem cell transplant recipients: a retrospective cohort study"],"prefix":"10.1186","volume":"15","author":[{"given":"Nicole","family":"Harrison","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margit","family":"Mitterbauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selma","family":"Tobudic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Kalhs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Werner","family":"Rabitsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hildegard","family":"Greinix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heinz","family":"Burgmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgit","family":"Willinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Presterl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Forstner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,12,29]]},"reference":[{"issue":"8","key":"1329_CR1","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/bmt.2009.255","volume":"44","author":"C Mackall","year":"2009","unstructured":"Mackall C, Fry T, Gress R, Peggs K, Storek J, Toubert A. Background to hematopoietic cell transplantation, including post transplant immune recovery. Bone Marrow Transplant. 2009;44(8):457\u201362.","journal-title":"Bone Marrow Transplant"},{"issue":"8","key":"1329_CR2","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1086\/591969","volume":"47","author":"C Garcia-Vidal","year":"2008","unstructured":"Garcia-Vidal C, Upton A, Kirby KA, Marr KA. Epidemiology of invasive mold infections in allogeneic stem cell transplant recipients: biological risk factors for infection according to time after transplantation. Clin Infect Dis. 2008;47(8):1041\u201350.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"1329_CR3","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1086\/595846","volume":"48","author":"D Neofytos","year":"2009","unstructured":"Neofytos D, Horn D, Anaissie E, Steinbach W, Olyaei A, Fishman J, et al. Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry. Clin Infect Dis. 2009;48(3):265\u201373.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"1329_CR4","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1056\/NEJMoa061098","volume":"356","author":"AJ Ullmann","year":"2007","unstructured":"Ullmann AJ, Lipton JH, Vesole DH, Chandrasekar P, Langston A, Tarantolo SR, et al. Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease. N Engl J Med. 2007;356(4):335\u201347.","journal-title":"N Engl J Med"},{"issue":"10","key":"1329_CR5","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1086\/422312","volume":"39","author":"JA Burik van","year":"2004","unstructured":"van Burik JA, Ratanatharathorn V, Stepan DE, Miller CB, Lipton JH, Vesole DH, et al. Micafungin versus fluconazole for prophylaxis against invasive fungal infections during neutropenia in patients undergoing hematopoietic stem cell transplantation. Clin Infect Dis. 2004;39(10):1407\u201316.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"1329_CR6","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/j.1365-2141.2011.08838.x","volume":"155","author":"DI Marks","year":"2011","unstructured":"Marks DI, Pagliuca A, Kibbler CC, Glasmacher A, Heussel CP, Kantecki M, et al. Voriconazole versus itraconazole for antifungal prophylaxis following allogeneic haematopoietic stem-cell transplantation. Br J Haematol. 2011;155(3):318\u201327.","journal-title":"Br J Haematol"},{"issue":"5","key":"1329_CR7","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/bmt.2010.175","volume":"46","author":"J Maertens","year":"2011","unstructured":"Maertens J, Marchetti O, Herbrecht R, Cornely OA, Fluckiger U, Frere P, et al. European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3\u20132009 update. Bone Marrow Transplant. 2011;46(5):709\u201318.","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"1329_CR8","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1093\/infdis\/171.6.1545","volume":"171","author":"MA Slavin","year":"1995","unstructured":"Slavin MA, Osborne B, Adams R, Levenstein MJ, Schoch HG, Feldman AR, et al. Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation--a prospective, randomized, double-blind study. J Infect Dis. 1995;171(6):1545\u201352.","journal-title":"J Infect Dis"},{"issue":"12","key":"1329_CR9","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1086\/588660","volume":"46","author":"B Pauw De","year":"2008","unstructured":"De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T, et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer\/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC\/MSG) Consensus Group. Clin Infect Dis. 2008;46(12):1813\u201321.","journal-title":"Clin Infect Dis"},{"issue":"Suppl 1","key":"1329_CR10","doi-asserted-by":"crossref","first-page":"i5","DOI":"10.1093\/jac\/dkq437","volume":"66","author":"L Pagano","year":"2011","unstructured":"Pagano L, Akova M, Dimopoulos G, Herbrecht R, Drgona L, Blijlevens N. Risk assessment and prognostic factors for mould-related diseases in immunocompromised patients. J Antimicrob Chemother. 2011;66 Suppl 1:i5\u201314.","journal-title":"J Antimicrob Chemother"},{"issue":"11","key":"1329_CR11","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1111\/1469-0691.12120","volume":"19","author":"Y Sun","year":"2013","unstructured":"Sun Y, Xu L, Liu D, Zhang X, Han W, Wang Y, et al. Incidence of invasive fungal disease after unmanipulated haploidentical stem cell transplantation was significantly higher than that after HLA-matched sibling transplantation. Clin Microbiol Infect. 2013;19(11):1029\u201334.","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"1329_CR12","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1182\/blood-2003-02-0456","volume":"102","author":"T Fukuda","year":"2003","unstructured":"Fukuda T, Boeckh M, Carter RA, Sandmaier BM, Maris MB, Maloney DG, et al. Risks and outcomes of invasive fungal infections in recipients of allogeneic hematopoietic stem cell transplants after nonmyeloablative conditioning. Blood. 2003;102(3):827\u201333.","journal-title":"Blood"},{"issue":"15","key":"1329_CR13","first-page":"00026","volume":"S1684\u20131182","author":"YC Liu","year":"2015","unstructured":"Liu YC, Chien SH, Fan NW, Hu MH, Gau JP, Liu CJ, et al. Incidence and risk factors of probable and proven invasive fungal infection in adult patients receiving allogeneic hematopoietic stem cell transplantation. J Microbiol Immunol Infect. 2015;S1684\u20131182(15):00026\u20132. doi: 10.1016\/j.jmii.2015.01.002 .","journal-title":"J Microbiol Immunol Infect"},{"issue":"2","key":"1329_CR14","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1046\/j.1365-2141.2002.03259.x","volume":"116","author":"R Martino","year":"2002","unstructured":"Martino R, Subira M, Rovira M, Solano C, Vazquez L, Sanz GF, et al. Invasive fungal infections after allogeneic peripheral blood stem cell transplantation: incidence and risk factors in 395 patients. Br J Haematol. 2002;116(2):475\u201382.","journal-title":"Br J Haematol"},{"issue":"6","key":"1329_CR15","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/bmt.2009.39","volume":"44","author":"M Mikulska","year":"2009","unstructured":"Mikulska M, Raiola AM, Bruno B, Furfaro E, Van Lint MT, Bregante S, et al. Risk factors for invasive aspergillosis and related mortality in recipients of allogeneic SCT from alternative donors: an analysis of 306 patients. Bone Marrow Transplant. 2009;44(6):361\u201370.","journal-title":"Bone Marrow Transplant"},{"issue":"17","key":"1329_CR16","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1056\/NEJMoa0802629","volume":"359","author":"PY Bochud","year":"2008","unstructured":"Bochud PY, Chien JW, Marr KA, Leisenring WM, Upton A, Janer M, et al. Toll-like receptor 4 polymorphisms and aspergillosis in stem-cell transplantation. N Engl J Med. 2008;359(17):1766\u201377.","journal-title":"N Engl J Med"},{"issue":"12","key":"1329_CR17","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.bbmt.2005.09.004","volume":"11","author":"AH Filipovich","year":"2005","unstructured":"Filipovich AH, Weisdorf D, Pavletic S, Socie G, Wingard JR, Lee SJ, et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant. 2005;11(12):945\u201356.","journal-title":"Biol Blood Marrow Transplant"},{"issue":"6","key":"1329_CR18","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/bmt.2011.110","volume":"47","author":"A Gratwohl","year":"2012","unstructured":"Gratwohl A. The EBMT risk score. Bone Marrow Transplant. 2012;47(6):749\u201356.","journal-title":"Bone Marrow Transplant"},{"issue":"14","key":"1329_CR19","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1016\/j.ejca.2009.05.001","volume":"45","author":"G Maschmeyer","year":"2009","unstructured":"Maschmeyer G, Beinert T, Buchheidt D, Cornely OA, Einsele H, Heinz W, et al. Diagnosis and antimicrobial therapy of lung infiltrates in febrile neutropenic patients: Guidelines of the infectious diseases working party of the German Society of Haematology and Oncology. Eur J Cancer. 2009;45(14):2462\u201372.","journal-title":"Eur J Cancer"},{"issue":"4","key":"1329_CR20","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1128\/JCM.06423-11","volume":"50","author":"J D\u2019Haese","year":"2012","unstructured":"D\u2019Haese J, Theunissen K, Vermeulen E, Schoemans H, De Vlieger G, Lammertijn L, et al. Detection of galactomannan in bronchoalveolar lavage fluid samples of patients at risk for invasive pulmonary aspergillosis: analytical and clinical validity. J Clin Microbiol. 2012;50(4):1258\u201363.","journal-title":"J Clin Microbiol"},{"issue":"9","key":"1329_CR21","volume":"8","author":"LC Fan","year":"2013","unstructured":"Fan LC, Lu HW, Cheng KB, Li HP, Xu JF. Evaluation of PCR in bronchoalveolar lavage fluid for diagnosis of Pneumocystis jirovecii pneumonia: a bivariate meta-analysis and systematic review. PLoS One. 2013;8(9), e73099.","journal-title":"PLoS One"},{"issue":"2","key":"1329_CR22","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1128\/JCM.40.2.490-494.2002","volume":"40","author":"HH Larsen","year":"2002","unstructured":"Larsen HH, Masur H, Kovacs JA, Gill VJ, Silcott VA, Kogulan P, et al. Development and evaluation of a quantitative, touch-down, real-time PCR assay for diagnosing Pneumocystis carinii pneumonia. J Clin Microbiol. 2002;40(2):490\u20134.","journal-title":"J Clin Microbiol"},{"issue":"8","key":"1329_CR23","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1086\/651263","volume":"50","author":"DP Kontoyiannis","year":"2010","unstructured":"Kontoyiannis DP, Marr KA, Park BJ, Alexander BD, Anaissie EJ, Walsh TJ, et al. Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001\u20132006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database. Clin Infect Dis. 2010;50(8):1091\u2013100.","journal-title":"Clin Infect Dis"},{"issue":"8","key":"1329_CR24","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1016\/j.bbmt.2013.05.018","volume":"19","author":"AK Omer","year":"2013","unstructured":"Omer AK, Ziakas PD, Anagnostou T, Coughlin E, Kourkoumpetis T, McAfee SL, et al. Risk factors for invasive fungal disease after allogeneic hematopoietic stem cell transplantation: a single center experience. Biol Blood Marrow Transplant. 2013;19(8):1190\u20136.","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"1329_CR25","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/CCO.0b013e3280148a2f","volume":"19","author":"K Kojouri","year":"2007","unstructured":"Kojouri K, George JN. Thrombotic microangiopathy following allogeneic hematopoietic stem cell transplantation. Curr Opin Oncol. 2007;19(2):148\u201354.","journal-title":"Curr Opin Oncol"},{"issue":"13","key":"1329_CR26","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1056\/NEJM199203263261301","volume":"326","author":"JL Goodman","year":"1992","unstructured":"Goodman JL, Winston DJ, Greenfield RA, Chandrasekar PH, Fox B, Kaizer H, et al. A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation. N Engl J Med. 1992;326(13):845\u201351.","journal-title":"N Engl J Med"},{"key":"1329_CR27","unstructured":"Maertens J, Girmenia C, Duarte R, Ribaud P. ECIL 5: primary antifungal prophylaxis. http:\/\/www.kobe.fr\/ecil\/telechargements2013\/ECIL5antifungalprophylaxis%2020062014Final.pdf ; 2013. Accessed date: 21 September 2013."},{"issue":"9","key":"1329_CR28","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1093\/jac\/dks189","volume":"67","author":"J Auberger","year":"2012","unstructured":"Auberger J, Lass-Florl C, Aigner M, Clausen J, Gastl G, Nachbaur D. Invasive fungal breakthrough infections, fungal colonization and emergence of resistant strains in high-risk patients receiving antifungal prophylaxis with posaconazole: real-life data from a single-centre institutional retrospective observational study. J Antimicrob Chemother. 2012;67(9):2268\u201373.","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"1329_CR29","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/phar.1533","volume":"35","author":"AJ Guarascio","year":"2015","unstructured":"Guarascio AJ, Slain D. Review of the new delayed-release oral tablet and intravenous dosage forms of posaconazole. Pharmacotherapy. 2015;35(2):208\u201319.","journal-title":"Pharmacotherapy"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-015-1329-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,23]],"date-time":"2017-06-23T22:40:40Z","timestamp":1498257640000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.biomedcentral.com\/1471-2334\/15\/584"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["1329"],"URL":"https:\/\/doi.org\/10.1186\/s12879-015-1329-6","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12]]},"article-number":"584"}}